ORAL COMMUNICATION 2: Movement disorders and traumatic brain injuries

8:45-8:55 am: Multimodal Neuroimaging Assessment of MMAE for CSDH on the Integrity of Subjacent Brain, Alejandra Mosteiro
8:55-9:05 am: Persistent Male Cholinergic Vulnerability in De Novo Parkinson’s Disease: Longitudinal Insights from Clinical and Cholinergic Molecular Imaging, Eline De Meyer
9:05-9:15 am: PET imaging of presynaptic protein SV2A with [11C]UCB-J and [18F]SynVesT-1: a head-to-head comparison in people with Huntington’s disease and controls, Jolien Van Opstal
9:15-9:25 am: Imaging of presynaptic terminals with [18F]SynVesT-1 PET in premanifest Huntington’s disease, Jolien Van Opstal
9:25-9:35 am: Clinical Utility of [¹²³I]Ioflupane (DATSCAN) in Guiding Dopaminergic Therapy for Parkinsonism, José Pedro Escaleira
9:35-9:45 am: Cognitive impairment in individuals with chronic spinal cord injury: a Flanker task-based functional magnetic resonance imaging study, Jothini Sritharan
9:45-9:55 am: Initial evaluation of 18F-AV133 imaging on the ultra-high performance United Imaging NeuroEXPLORER PET/CT brain scanner for Parkinson’s Disease
9:55-10:05 pm: Parametric imaging of [18F]PE2I uptake in the substantia nigra pars compacta is feasible with ultra-high performance NeuroEXPLORER PET, Louis Versweyveld
10:05-10:15 am: Parietal Regional Homogeneity Predicts Recovery Outcomes in Older Patients with Mild Traumatic Brain Injury, Yadong Liu